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ABSTRACT 
Coffee bean extract (Chlorogenic Acid), Disease Modifying Anti-Rheumatoid Drug (DMARD) agent in the treatment of Rheumatoid Arthritis is 
believed to inhibit the production of TNF-α by blocking the cell associated conversion of TNF Precursor to mature proteins this, halting the 
proliferation of synovitis.CGA inhibit the proliferation of the fibroblast-like synoviocyte cell line (RSC-364), stimulated by interleukin (IL)-6, 
through inducing apoptosis. CGA inhibit the inflammatory proliferation of RSC-364 cells mediated by IL-6 through inducing apoptosis. CGA was 
also able to suppress the expression levels of key molecules in the JAK/STAT and NF-κB signaling pathways, and inhibit the activation of these 
signaling pathways in the inflammatory response through IL-6-mediated signaling, thereby resulting in the inhibition of the inflammatory 
proliferation of synoviocytes. The aim of the present study was to formulate and evaluate coffee bean extract (chlorogenic acid) solid lipid 
nanoparticles using a positive charge on it by means of enabling lymphatic uptake. Coffee bean extract (chlorogenic acid) solid lipid 
nanoparticles were prepared by melt emulsification-high pressure homogenization method and the particle size, PDI and % entrapment 
efficiency was found to be 210nm, 0.455 and 91.18% .ex vivo endocytic uptake studies revealed engrossment of endocytic pathways in the 
uptake of solid lipid nanoparticles from intestine. 
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1. INTRODUCTION  
 Coffee bean extract (Chlorogenic Acid), has been reported to 
serve as Disease Modifying Anti-Rheumatoid Drug (DMARD). 
Chlorogenic acid given orally in a dose of 40mg/Kg is 
reported to inhibit the production of TNF-α by blocking the 
cell associated conversion of TNF Precursor to mature 
proteins thus halting the proliferation of synovitis 1,2. 
Solid lipid nanoparticles (SLN) are colloidal drug carriers 
and have particle size ranging from 50 nm to 1000 nm and 
its advantages include biocompatibility, stability and 
protects drug against chemical degradation5. SLN are 
reported to have ability to enter lymphatic circulation when 
administered orally through Peyer’s patch6,7,the factors such 
as particle size, zeta potential on particles are known to 
affect the uptake6 
The present work attempts to formulate chlorogenic acid in 
solid lipid nanoparticulate carrier by using principal of 
design of experiment (DOE) and demonstrate its lymphatic 
uptake by ex vivo everted rat gut sac model. 
2. MATERIAL AND METHODS: 
2.1. Materials 
Coffee bean extract was purchased from shamantak 
enterprises (pune, india). Glyceryl mono stearate (analab 
fine chemicals),chlorogenic acid (sigma aldrich) purchased 
locally. All the other chemicals and reagents were of 
analytical grade and procured from local sources. 
2.2 Methods 
2.2.1 Characterization of Coffee bean extract:  
2.2.1.1 Standard calibration curve of chlorogenic acid by 
UV-Visible spectrophotometry 
Solution of chlorogenic acid were prepared in concentration 
range of 5 to 30μg/ml in ethanol. The absorbance of resulting 
solutions was measured at 324 nm using double beam UV-
Visible Spectrophotometer (LABINDIA UV 3000) against 
ethanol as blank 10. 
2.2.1.2 Selection of lipid using solubility parameter:11,12  
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Selection of lipid for preparation of solid lipid nanoparticles 
was done on the basis of difference in the solubility 
parameter of drug and various lipids. The value of solubility 
parameter of the drug and each lipid was calculated on the 
basis of their Molecular Structure. The Molecular structure is 
having different groups as well as bonds and so ∆Eυ and Vm 
values are specific for each group. The    for each molecular 
structure was calculated by using the formula given below, 
and then the difference between the Solubility parameter of 
drug and the lipid was noted. 
  (      )0.5             ……. Equation (1) 
where, ∆Eυ -the energy of vaporization at a given 
temperature and  
Vm -the corresponding molar volume which is calculated 
from the known values of molecular weight and density. 
2.2.1.3 Selection of Surfactant System:13 
A mixture of Coffee bean extract (Chlorogenic Acid) and GMS 
in ratio 1:3 was melted at 70C. Aqueous phase was prepared 
by dissolving separately aqueous phase surfactants Tween 
80 (4%), sodium lauryl sulphate  (4%) and poloxamer 188 
(4%) into distilled water at 70C. Two phases were mixed at 
the same temperature followed by stirring under an over-
head stirrer at 800 rpm for 15 minutes to obtain a uniform 
emulsion, which was further subjected to high pressure 
homogenization at homogenization pressure (400 bars) and 
homogenization cycles (3). The resultant solid lipid 
nanoparticles were evaluated for particle size and PDI. The 
surfactant system was chosen depending upon the average 
diameter of the globules produced and Poly Dispersity Index 
(PDI) of the resultant emulsion upon employing the 
surfactant system. (Table 1). 
Table 1: Trial combinations of Surfactant used for 
preparation of Solid Lipid Nanoparticles 
Batches Water Phase Surfactant (2%) 
T1 Sodium Lauryl Sulphate 
T2 Poloxamer 188 
T3 Tween 80 
 
2.2.1.4 Drug Excipient Compatibility Studies: 
Compatibility of Coffee bean extract (Chlorogenic Acid) with 
GMS and Tween 80 was checked in physical mixtures (1:1 
ratio) stored at 400C for 30 days . Fourier transform- infrared 
spectroscopic analysis (FT-IR) was carried out in Shimadzu-
IR Spectrophotometer. Samples were dispersed in KBr and 
compressed into pellet by application of pressure. The 
canning range was 4000-400 cm-1 and resolution was 1cm-1. 
2.2.2 Optimization and formulation of Coffee bean 
extract SLN: 
The  Coffee bean extract was added to chosen lipid at 70C. 
Aqueous phase was prepared by dissolving surfactant into 
distilled water at 70C. Two phases were mixed at the same 
temperature followed by stirring under an over-head stirrer 
at 800 rpm for 15 minutes to obtain a uniform emulsion. This 
emulsion was further subjected to high pressure 
homogenization, the process parameters such as surfactant 
(Tween 80) concentration (2%, 4%, 6%), homogenization 
pressure (400,800,1200 bars) and homogenization cycles (3, 
6, 9) were optimized using a 3 factor  3 level Box Behnken 
Design to obtain SLN of smallest particle size and highest % 
entrapment. 
The layout of the experimental design is shown in table 2 and 
3.
  
Table 2: Factor combination and respons parameters for the Box Behnken Design 
Sr. No. Factors Responses 
1 Concentration of Aqueous 
Surfactant (Tween 80) (%) 
-1 0 +1 Percentage 
Entrapment 
Efficiency (%) 
2 Homogenisation pressure (Bar) -1 0 +1 Particle Size (nm) 
3 homogenization cycles (No) -1 0 +1  
 
Table 3: Translation of experimental conditions into physical units for preparation of Coffee bean extract(Chlorogenic Acid) 
SLN. 
Sr. No. Factor 1(A): Aqueous Phase 
Surfactant (Tween 80) (%) 
Factor 2 (B):homogenization pressure 
(bar) 
Factor 3 (C): homogenization 
cycles (No) 
-1 2 400 3 
0 4 800 6 
+1 6 1200 9 
A blank SLN batch (excluding coffee bean extract) as per optimized formula was also prepared similarly. 
 
2.2.3 Characterization of Coffee bean extract SLN:  
2.2.3.1 Determination of Particle size: 
The particle size analysis of the prepared SLN dispersions 
was performed using Malvern Zetasizer ZS 90 (Malvern 
Instruments, Worcestershire, UK), utilizing laser diffraction 
with beam length 2.40 mm, range lens of 300 RF mm, and at 
14.4% obscuration. The sample was diluted with distilled 
water prior to the analysis. The mean diameter and the poly 
dispersity index of each batch was recorded. 
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2.2.3.2 Determination of Entrapment Efficiency: 
The SLN dispersion was subjected to centrifugation at 
20,000 rpm for 15 minutes and the pellets of sediment Solid 
Lipid Nanoparticle was separated from the clear supernatant 
liquid. The pellet was analysed for the chlorogenic acid 
content spectrophotometrically at 324 nm using ethanol as a 
solvent, similarly the supernatant was also analysed for 
unentrapped Coffee bean extract (Chlorogenic Acid). EE was 
calculated according to the equation 2. 
 
     
                                   
                                                     
     …………. Equation (2) 
 
2.2.3.3 Differential Scanning Calorimetry (DSC): 
Differential scanning calorimetry (DSC) studies were carried 
out on Coffee bean extract (Chlorogenic Acid), and its 
physical mixture with GMS using Mettler Toledo DSC 823 *e 
software (Columbia, USA). Samples were accurately weighed 
and heated in sealed aluminium pans at a rate 10°C/min 
between 30- 300°C temperature rang under nitrogen 
atmosphere at flow rate of 40ml/minute.Empty aluminium 
pan was used as a reference.  
2.2.4 Ex vivo endocytic  uptake  study15: 
It has been seen that there are multiple methods reported 
for determination of uptake of lipid nanoparticles from an 
intestine. In order to study the uptake of Coffee bean extract 
SLN across rat intestine, ex vivo endocytic uptake study 
using everted rat intestine model was done. Segments of 
small intestine of sacrificed rat were procured, cleaned and 
everted using a glass rod.16,17 One end of the intestinal 
segment was sealed using a silk suture, while from the other 
open end, 1 ml of phosphate buffer of pH 6.8 was added 
inside and sealed using silk suture. The resultant sac was 
further incubated in a dispersion containing Coffee bean 
extract SLN. Coffee bean extract (Chlorogenic Acid) 
concentration in the phosphate buffer was estimated using 
UV method. 
The uptake mechanism of the SLN by the intestinal cells was 
evaluated in detail, everted gut sacs as described above were 
also incubated with specific endocytic inhibitors like 
chlorpromazine (concentration of 10 μg/ml) and nystatin 
(concentration of 25μg/ml) at 37 °C for 30mins and in Coffee 
bean extract SLN dispersions at 4°C. After 30mins of 
incubation the phosphate buffer from the intestinal sacs 
were carefully collected in test tubes and subjected to 
spectrophotometric analysis. 
3. RESULTS AND DISCUSSION 
3.1.1 Standard calibration curve of chlorogenic acid by 
UV-Visible Spectrophotometry: 
Three absorption maxima viz 221, 253 and 324 nm for 
chlorogenic acid are reported  in literature [18].. However the 
linearity was seen at  324 nm; hence all analytical 
measurements were done at 324 nm. 
Ethanolic solution of chlorogenic acid obeyed Beer’s law 
between concentration range of 5-30μg/ml. the equation of 
line and R2 was found to be y = 0.036x + 0.030 and R2= 0.993 
respectively figure 1. 
 
Figure 1: Calibration curve of chlorogenic acid 
3.1.2 Selection of Lipid based on Solubility 
Parameter:[11,12] 
The solubility parameter of a liquid δ, defined as the square 
root of the cohesive energy density is a quantity which, in 
conjunction with suitable theory, allows one to estimate 
several thermodynamic properties of solutions. The 
cohesive energy density itself is defined as the ratio of the 
energy of vaporization, ∆Eυ to the molar volume both 
referred to the same temperature. Solubility parameters are 
widely used to describe the cohesive forces within materials 
and have been used to describe many physical properties of 
a material and predict interactions between materials. 
Fedor’s group contribution method of estimating solubility 
parameter, also based on group additive constants is 
believed to be superior to Small’s method for two reasons: 
1) the contribution of a much larger number of functional 
groups have been evaluated, and 2) the method requires 
only a knowledge of the structural formula of the com- 
pound. 
The combination of drug and lipid with least difference of 
solubility parameter gives highest solubility hence GMS was 
selected on this basis as the lipid carrier. Table 4 
 
Table 4: Solubility Parameter of Coffee bean extract(Chlorogenic Acid)  and various lipids together with their differences. 
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Concentration (μg/ml) … 
Sr. No. Drug/ Lipid Name Solubility Parameter (MPa1/2) Difference with Coffee bean 
extract(Chlorogenic Acid) (∆δ) 
1 Chlorogenic Acid 25.56 -- 
2 Compritol 888 ATO 21.26 4.3 
3 Stearic Acid 18.66 6.9 
4 Precirol ATO 5 21.63 3.93 
5 Emulcire 61 19.27 6.29 
6 GMS 22.28 3.28 
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3.1.3 Selection of Surfactant System:[13] 
SLN containing sodium lauryl Sulphate (SLS) produced 
substantially smaller particle size 240.25 nm, but owing to 
high poly dispersity index (0.528 ) and associated instability, 
it was eliminated as a choice.Other surfactant such as 
poloxamer 188 had smaller particle size 208.73 nm and also 
low poly dispersity index (0.480 ) but due to its gelation on 
storage it was also not considered for further study. Tween 
80 resulted in particle size of 220.5 nm and PDI of 0.455 and 
hence this was chosen to carry out the study in Table 5.
 
Table 5: Represents various findings of different amalgamations of lipid and water  surfactant. 
Batches 
 
Solid Lipid (GMS) 
(%) 
Water Phase Surfactant 
(Tween 80) (%) 
Mean *Particle 
Size (nm) 
*PDI Observation 
B1 GMS Sodium Lauryl Sulphate 240.25 0.528 Higher Particle Size 
B2 Poloxamer 188 208.73 0.480 Has Caused Gelation on storage   
B3 Tween 80 220.5 0.455 Stable on Storage 
*n=3 i.e. average of three readings  
Tween 80 as a long chain surfactant provides aqueous phase stability to the emulsion formed thus leading to the formation of 
an emulsion system with low particle size and PDI. 
 
3.1.4 Drug Excipient Compatibility Studies: 
 
Figure 2: FT-IR spectroscopy of Coffee bean extract 
The compatibility data of Coffee bean extract(Chlorogenic 
Acid) with potential formulation excipients studied by FT-IR 
spectroscopy is presented in Figure 2. The characteristics 
peaks of Coffee bean extract(Chlorogenic Acid)  are retained. 
The peaks were observed at , (3048 cm-1)- Aromatic C-H 
Stretch, (3300 cm-1)- O-H, (2950 cm-1)- Aliphatic C-H Stretch,  
with only minor shifts in wave number thus suggesting that 
there is no interaction between the Coffee bean 
extract(Chlorogenic Acid)  and other excipients. Hence drug- 
excipients compatibility was established. 
 
3.1.5 Optimization and formulation of Coffee bean extract SLN: 
Table 6: Experimental run and responses for optimization of Coffee bean extract SLN formula using Box- Behnken design. 
Formulation 
Code 
Run Factor 1 (A): 
Concentration of 
Surfactant 
(Tween 80) (%) 
Factor 2 (B): 
Homogenization 
pressure (bar) 
Factor 3 (C):  
homogenization 
cycles (no.) 
Response1 
*Particle 
Size 
(nm) 
Response 2 
*Entrapment 
Efficiency 
(%) 
5 1 2 800 3 545 86.29 
8 2 6 800 9 430 88.25 
3 3 2 1200 6 309 89.68 
4 4 6 1200 6 210 91.18 
1 5 2 400 6 660 75.47 
10 6 4 1200 3 261 90.88 
13 7 4 800 6 502 74.11 
2 8 6 400 6 531 76.66 
9 9 4 400 3 698 74.88 
6 10 6 800 3 470 91.48 
7 11 2 800 9 510 92.62 
11 12 4 400 9 564 85.19 
12 13 4 1200 9 249 90.2 
*n=3 i.e. average of three readings 
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3.1.5.1 Preparation of Coffee bean extract Solid Lipid 
Nanoparticles (SLN):  
Coffee bean extract SLN were prepared by melt 
emulsification method followed by high pressure 
homogenization. Coffee bean extract(Chlorogenic Acid) SLN 
were prepared as per the experimental design given in the 
table 4 and were evaluated for particle size and entrapment 
efficiency. The Box-Behnken design reduces number of 
experiments in a 3- Factor, 3-Levels experimental design 
from 27 to 13. Another advantage of the Box-Behnken design 
is that it does not contain combinations for which all factors 
are simultaneously screened at their highest or lowest levels. 
3.1.6 Characterisation of Coffee bean extract SLN 
3.1.6.1 Determination of  Particle size: 
The particle size of SLN ranged between  698- 210 nm. It was 
seen that the concentration of tween 80 and homogenization 
pressure and number of homogenization cycles contributed 
in reduction of particle size. However with increase in 
homogenization cycles the particle size increased marginally 
this can be explained to high amount of collisions or very 
high surface area generated which can not be stabilized by 
available surfactant. On the other hand with decrease in 
particle size the migration of drug from emulsion globules to 
dispersion medium increased also aided by high temperature 
and surfactant concentration, resulting in reduction of drug 
entrapment. 
 The statistical model generated for the particle size 
Particle Size = +502.00-47.88A-178.00B-27.63C-
1.2546.90+7.50AB-1.25AC+30.50BC-
14.37A2+60.12B2+1.12C2 
Equation shows that tween 80 had a limited effect of 
reducing the particle size, in comparison to homogenization 
pressure that can be attributed to high density fluid-dynamic 
energy conditions. The interaction term AB i.e. as the 
surfactant concentration and homogenization pressure 
contributed to decrease in particle size. Also at low 
concentration of tween 80 protective layer around the 
particle was not formed thus leading to the aggregation of 
particles. 
The interaction term AC showed increase in particle size 
which is due to high surface area generated by more 
homogenization cycles which cannot be protected by 
surfactant and hence marginally the particle size is 
increased. 
The interaction term BC i.e. high homogenization pressure 
and homogenization cycles the particle size was found to be 
decreasing. Similar effects were shown in figure 3, 4 and 5. 
 
Figure 3: Response surface plot showing influence of 
Concentration of Surfactant  and homogenization pressure 
on Particle size. 
 
Figure 4: Response surface plot showing influence of 
homogenization pressure and homogenization cycle on 
Particle size. 
 
Figure 5: Response surface plot showing influence of 
Concentration of Surfactant  and homogenization cycles on 
Particle size. 
3.1.6.2 Determination of Entrapment Efficiency: 
Equation 4 for Entrapment Efficiency: 
                                           
                                                
Equation 4 
The model indicates that as the concentration of surfactant 
goes on decreasing the drug incorporation ability increases 
and thus the entrapment efficiency increases Equation (4). 
As the particle size goes on decreasing the chances of drug 
expulsion increases and thus the entrapment efficiency 
decrease. On the other hand with decrease in particle size the 
migration of drug from emulsion globules to dispersion 
medium increased also aided by high temperature and 
surfactant concentration, resulting in reduction of drug 
entrapment. 
The interaction term AC i.e. the concentration of surfactant 
and homogenization cycle was seen to contribute reduction 
in drug entrapment which is because lower particle size of 
globules leading to enhanced area of migration of drug to 
aqueous phase.  
The interaction term BC i.e. Entrapment efficiency was not 
highly affected by homogenization pressure and 
homogenization cycle. Similar effects were shown in figure 
6,7 and 8. 
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Figure 6: Response surface plot showing influence of 
Concentration of Surfactant and of homogenization pressure 
on Entrapment Efficiency. 
 
Figure 7: Response surface plot showing influence of 
Homogenization pressure and  homogenization cycle on 
Entrapment Efficiency. 
 
Figure 8: Response surface plot showing influence of 
Concentration of surfactant and    homogenization cycle on 
Entrapment Efficiency. 
3.1.6.3 Validation of the Response Surface Methodology 
(RSM): 
To evaluate the findings of the RSM, verification run was 
carried out and no significant difference was found between 
the theoretical and the actual values of particle size and 
entrapment efficiency. The responses were evaluated for 
particle size and entrapment efficiency as shown in the table 
7. The composition, actual and predicted values of the 
responses and the % prediction error are shown in the table 
below. Thus, the formulation batch giving minimum particle 
size and maximum entrapment was chosen as the optimized 
batch. Thus, the optimized value of surfactant concentration 
5.9%, homogenization pressure1200 bar and 3 
homogenization cycles were predicted to yield SLN with 
least possible particle size and higher entrapment. 
 
Table 7: Check Points for optimization, actual, predicted value and % error (n=3, Mean± SD) 
Formulation 
Code 
Composition of 
optimized 
formulation 
Response Predicted 
Value 
Actual Value % Error 
X1 X2 X3 
OF1 6 1200 9 Y1 209.0nm 210nm 1.0 
Y2 93.55% 91.18% 2.37 
 
3.1.7 Evaluation of Optimized Solid Lipid Nanoparticles: 
3.2.7.1 Determination of Particle Size and Entrapment Efficiency: 
The particle size of Coffee bean extract SLN was seen to be increased from 178 nm of Blank SLNs to 210 nm and entrapment 
efficiency was 91.18 as seen in Table 8.  
Table 8: The particle size, entrapment efficiency of Blank-SLN, Coffee bean extract-SLN are given in table. (n=3, Mean± SD) 
Formulation Particle Size 
(nm) 
Polydispersity 
Index 
Entrapment 
Efficiency  
Blank SLNs 178 0.227 --- 
CGA-SLNs 210 0.455 91.18 
 
3.1.7.2 Differential Scanning Calorimetry (DSC): 
The melting endotherm of Chlorogenic acid and GMS was 
observed at 203ºC and 70.08ºC respectively (Figure 8). The 
DSC thermograms of Chlorogenic acid SLN showed an 
endotherm at 69 ºC this slight decrease in melting 
endotherm  can be attributed to decreased crystallinity of 
GMS in SLN. However the disappearance of chlorogenic acid 
melting endotherm was proof of drug getting molecularly 
entrapped in the GMS matrix. 
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Figure 8: DSC thermograms of A] Chlorogenic acid , B] GMS and C] Chlorogenic acid Solid Lipid Nanoparticles (CGA-SLNs) 
 
3.2 Ex-vivo Studies: 
Numerous Literature[23,24]identifies energy dependent 
endocytic processes for the uptake of nanoparticles of 
which primary are clathrin-mediated endocytosis 
(receptor-mediated process), caveolae-mediated 
endocytosis (receptor-mediated process) and clathrin-
caveolae independent process, importantly, 
micropinocytosis (actin dependent non receptor- mediated 
process). In micropinocytosis, large (0.5-2μm) vesicular 
structures at the cell surface called macropinosomes are 
formed; particle smaller than 2μm can be internalized into 
enterocytes by this mechanism[23]micropinocytosis being 
non-specific pathway for endocytosis uptake, it was not 
evaluated for uptake of Coffee bean extract(Chlorogenic 
Acid)-SLNs.[24] 
 
Figure 9: Ex-vivo apparent permeability of Coffee bean 
extract SLN at A) Coffee bean extract SLN at 37◦C B) Coffee 
bean extract  SLN at 4◦C C) In presence of Chlorpromazine 
at 37◦C, D) In Presence of Nystatin at 37◦C  
 
To explicate the cellular uptake pathways for Solid Lipid 
Nanoparticles, the experiment was carried out in the 
presence of inhibitors of clathrin-mediated endocytosis 
and caveolae-mediated endocytosis. Chlorpromazine, a 
cationic, amphiphilic drug, is reported to inhibit clathrin-
mediated endocytosis by causing clathrin to accumulate in 
late endosomes and reducing its availability on the 
enterocytes surface[23]while caveolae, special type of lipid 
rafts rich in cholesterol and sphingo lipids are flask- 
shaped invagination on the plasma membrane to engulf 
cargo molecules or carriers binding to their surface. 
Antifungal drug nystatin causes cholesterol sequestration 
thus blocking the caveolae mediated uptake.[15] 
Figure 9 represents the apparent permeability of the 
Coffee bean extractSLN at 37◦C, at 4◦C, in presence of 
Chlorpromazine at 37◦C and in presence of Nystatin at 37 
◦C measured for 30 minutes. It was evident from the 
results that the apparent permeability in presence of 
Chlorpromazine was reduced by 29.8% as compared to 
that in absence of Chlorpromazine. Similarly, the apparent 
permeability in presence of Nystatin was also found to be 
reduced 19.6% thus concluding the contribution of both 
clathrin and caveolae mediated process in the uptake of 
SLN. After application of single way ANOVA followed by 
Tukey's multiple comparison test, the differencebetween 
A, B, C, D and E was found significant (p < 0.001). The 
reduction in the apparent permeability at 4 °C by 76.2% in 
comparison with that at 37 °C also confirms the 
mechanism. 
4. CONCLUSION: 
The study investigated formulation optimization of SLN 
containing Coffee bean extract (Chlorogenic Acid) DMARD 
of phytochemical origin for lymphatic uptake which can 
reduce side effects and improve concentration of active at 
inflamed site in treatment of RA.  The study through ex vivo 
study using everted rat gut sac model established that 
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Coffee bean extract (Chlorogenic Acid) SLN with particle 
size 210 nm of Coffee bean extract SLN can effectively be 
taken up by lymphatic route, as demonstrated by lack of 
uptake in presence of lymphatic uptake blockers.  
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